Cue the “Rocky Music”, Bydureon a “blockbuster contender”


 

According to FierceBiotech, Bydureon is on their “Top 15 Blockbuster Contenders” list.

We couldn’t help but think of the “Rocky” comparisons, Amylin has been down on the mat a few times, but has always comes back swinging.

We will know much more over the next 12 months.  The Bydureon PDUFA is the end of January.  Amylin/Lilly have had several years to prepare for this launch. The data is very good, the molecule is established, but will a once-weekly get the Amylin/Lilly alliance the championship belt?  And if so of what weight class, the middle-weights, or will the product presentation make some noise with the heavyweights?

Give me a shout, let’s take some wagers on market share for Bydureon by the end of 2012. aaron@metabolicmarkets.com

Advertisements
Post a comment or leave a trackback: Trackback URL.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: